Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
Paulsen SK, Pedersen SB, Jørgensen JO, Fisker S, Christiansen JS, Flyvbjerg A, Richelsen B. Paulsen SK, et al. Among authors: pedersen sb. J Clin Endocrinol Metab. 2006 Mar;91(3):1093-8. doi: 10.1210/jc.2005-1694. Epub 2005 Dec 20. J Clin Endocrinol Metab. 2006. PMID: 16368752 Clinical Trial.
Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
Kjaer TN, Ornstrup MJ, Poulsen MM, Jørgensen JO, Hougaard DM, Cohen AS, Neghabat S, Richelsen B, Pedersen SB. Kjaer TN, et al. Among authors: pedersen sb. Prostate. 2015 Sep;75(12):1255-63. doi: 10.1002/pros.23006. Epub 2015 May 4. Prostate. 2015. PMID: 25939591 Clinical Trial.
283 results